Extended Thromboprophylaxis for Medical Patients

Am J Med. 2020 Jan;133(1):9-11. doi: 10.1016/j.amjmed.2019.05.050. Epub 2019 Jun 24.

Authors

James E Dalen¹, Paul D Stein², Jennifer L Plitt³, Neha Jaswal⁴, Joseph S Alpert⁴

Affiliations

¹ College of Medicine, University of Arizona, Tucson. Electronic address: jdalenmd@gmail.com.
² Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing.
³ Department of Emergency Medicine, University of Arizona, Tucson.
⁴ College of Medicine, University of Arizona, Tucson.

PMID: 31247174
DOI: 10.1016/j.amjmed.2019.05.050

No abstract available

Publication types

Editorial

MeSH terms

Aftercare / methods
Anticoagulants / administration & dosage*
Benzamides / therapeutic use
Duration of Therapy*
Enoxaparin / therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Hospitalization
Humans
Length of Stay
Pulmonary Embolism / prevention & control*
Pyrazoles / therapeutic use
Pyridines / therapeutic use
Pyridones / therapeutic use
Rivaroxaban / therapeutic use
Venous Thromboembolism / prevention & control*
Venous Thrombosis / prevention & control*

Substances

Anticoagulants
Benzamides
Enoxaparin
Heparin, Low-Molecular-Weight
Pyrazoles
Pyridines
Pyridones
apixaban
betrixaban
Rivaroxaban